Filing Details
- Accession Number:
- 0001628280-22-031725
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-12 16:22:14
- Reporting Period:
- 2022-12-09
- Accepted Time:
- 2022-12-12 16:22:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1534120 | Avalo Therapeutics Inc. | AVTX | Pharmaceutical Preparations (2834) | 450705648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586785 | Arthur Garry Neil | C/O Avalo Therapeutics 540 Gaither Road, Suite 400 Rockville MD 20850 | Ceo And Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-09 | 2,083 | $4.42 | 9,220 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
Billionaire Hedge Funds
